Home > Insider Trading > Charles River Laboratories International Inc.

Charles River Laboratories International Inc. (CRL)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
11 - 20
Next >>

Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2023 Earnings Conference Call. This call is being recorded.

Keep Reading →

May 12th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Marc Lasry, Standard General, Third Point LLC, Irenic Capital Management, Millennium Management, Soroban Capital Partners, Point72 Asset Management, Vishay Precision Group Inc (VPG), Spruce Biosciences Inc (SPRB), and More

Billionaire investor Marc Lasry has reached a deal to sell his stake in the Milwaukee Bucks to Jimmy and Dee Haslam, owners of the National Football League’s Cleveland Browns, according to a person ...

Keep Reading →

February 27th, 2023 - Hedge Funds Insider Trading

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2022 Earnings Conference Call. This call is being recorded.

Keep Reading →

February 23rd, 2023 - News Transcripts

Should You Invest in Charles River Laboratories International (CRL) for the Long-Term?

Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

December 22nd, 2022 - Hedge Fund Investor Letters News

16 Large-Cap Stocks with Insider Buying

Insider buying is a popular way to assess the potential of a company and can be a good indicator to gauge a stock's performance.

Keep Reading →

December 15th, 2022 - Hedge Funds News

Here's What Makes Charles River Laboratories International (CRL) a High Potential Long-Term Investment

Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth” second quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 3rd, 2022 - Hedge Fund Investor Letters News

Why These 5 Stocks Are Trending Today

Eli Lilly and Company (NYSE:LLY) is trending today after Jasper Hellweg of Argus raised his price target on the stock to $360 from $315.

Keep Reading →

September 30th, 2022 - Market Movers News

10 Stocks to Buy in 2022 According to John Rogers' Ariel Investments

In this article, we discuss 10 Stocks to Buy in 2022 According to John Rogers' Ariel Investments.

Keep Reading →

September 21st, 2022 - Hedge Funds News

10 Biggest Losers in Gabriel Plotkin's Melvin Capital Portfolio

In this article, we discuss the 10 biggest losers in Gabriel Plotkin's Melvin Capital portfolio.

Keep Reading →

May 26th, 2022 - Hedge Funds News

Here's Why You Should Buy Charles River Laboratories (CRL) Shares

ClearBridge Investments, an investment management firm, published its “All Cap Growth Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

April 5th, 2022 - Hedge Fund Investor Letters News